Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Don't Let Fear of Cancer Keep You From Doctor VisitsMaker Halts Distribution of Generic Zantac Due to Possible CarcinogenCould Profit Be a Factor in Kidney Transplant Decisions?Get Up-to-the-Minute Safety Alerts Sent Straight to Your InboxPurdue Pharma to Settle Opioid Crisis Lawsuits, May Pay Up to $12 BillionWould a Health Warning on Every Cigarette Help Smokers Quit?Docs Prescribe More Opioids at Certain Time of DayFDA Warns Juul About Illegal Marketing Claims and Pitch to YouthComing Soon: A 'Pot Breathalyzer'?More CT, MRI Scans Being Used, Despite Calls to Cut BackCancer Overtakes Heart Disease as #1 Killer of Middle-Aged in Wealthy NationsOxyContin Maker Purdue Offering Up to $12 Billion to Settle Opioid ClaimsThousands of Kidneys Thrown Away by U.S. Transplant CentersJudge Orders Johnson & Johnson to Pay $572 Million Over Opioid Drug CrisisEvery Sudden Infant Death Deserves a Closer Look: ReportYour Chocolate Pot 'Edible' Could Hold a Hidden DangerCBD Is the Rage, But More Science Needed on Safety, EffectivenessMany Parents Would Switch Doctors Over Vaccination Policy, Poll FindsPot Poisonings Among Kids, Teens Double After Medical Marijuana Law PassedNearly Half of U.S. Patients Keep Vital Secrets From Their DoctorsFDA Proposes Graphic Warning Labels on CigarettesMany Doctors Refusing Care of People Prescribed OpioidsAll U.S. Adults Should Be Screened for Illicit Drug Use, National Panel UrgesAmericans' Trust in Scientists Follows a Sharp Political DivideRaising Legal Smoking Age to 21 WorksPure CBD Won't Make You Fail a Drug Test, But…Health Tip: Donate Blood SafelyRoutine Screening for Pancreatic Cancer Not Warranted, Expert Panel SaysResearchers 'Spin' Clinical Trial Findings in Top Psych Journals: StudyMore 'Buyer Beware' Warnings for Unregulated Stem Cell ClinicsSome of Most Common, Deadly Cancers Get the Least Research MoneyTraveling Abroad? Make Sure Your Measles Shot Is Up to DateHey! That's the Wrong Knee, DoctorBlood Donations Needed: Red CrossKeep Unused Meds Out of the Hands of AddictsFew U.S. Universities Are Smoke-FreeNeed Emergency Air Lift to Hospital? It Could Cost You $40,000California Took on Anti-Vaxxers, and WonAnti-Vaccine Movement a 'Man-Made' Health Crisis, Scientists WarnAHA News: Even the Threat of Homelessness May Bring Higher Stroke RiskFDA Warns Two Kratom Marketers About False ClaimsExperts Want Doctors to Add Vaping to Youth Prevention PitchMany Health Care Workers With Flu, Colds Still Go to Work: StudyGlobal Efforts to Cut Smoking Show Mixed ResultsOne Simple Food Substitution Might Help Save the PlanetAHA News: 3 Simple Steps Could Save 94 Million Lives WorldwideRace Affects Life Expectancy in Major U.S. CitiesDrugstores Often Don't Have Opioid Antidote in Stock, Philly Study ShowsAntibiotics Pollute Rivers Worldwide: StudyAHA News: For LGBTQ Patients, Discrimination Can Become Barrier to Medical Care
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

Could the U.S. Mail Deliver Better Colon Cancer Screening Rates?

HealthDay News
by -- Robert Preidt
Updated: Mar 22nd 2019

new article illustration

FRIDAY, March 22, 2019 (HealthDay News) -- No one likes to get a colonoscopy, but new research suggests that mailing at-home colon cancer tests to folks who are overdue for their checks might prompt them to get screened.

"We believe that mailing kits directly to patients, which frames participation as the default, reduced steps in the screening process, making it easier for patients to get screened and catch colorectal cancer earlier or even potentially prevent it from occurring," said study senior author Dr. Chyke Doubeni. He is a professor at Penn Medicine in Philadelphia.

Colon cancer is the second leading cause of cancer death in the United States. But only six of 10 adults aged 50 to 75 -- the recommended age range for routine screening -- were screened in 2015.

Failure to get routine screening increases the risk of colon or rectal cancer death, the study authors noted in a Penn news release.

This study included nearly 900 patients who were overdue for colon cancer screenings. That meant they hadn't had a colonoscopy in 10 years, a flexible sigmoidoscopy in five years, or stool testing in the last year.

All of the patients were mailed a fecal immunochemical test kit from their primary care provider, and encouraged to complete the test at home and send it back within two months. Some were offered financial rewards for doing so, while others were not.

About 24 percent of patients mailed back completed kits within two months of receiving them, and 29 percent did so within six months. Financial incentives were not a factor, according to the report published online March 22 in JAMA Open Network.

Study author Dr. Shivan Mehta, associate chief innovation officer at Penn Medicine, pointed out that the response rate was relatively high considering that the researchers "only reached out to patients who had not been previously up-to-date, despite having a primary care clinician."

More information

The U.S. National Cancer Institute has more on colorectal cancer screening.




Facebook

Amazon Smile

To quit smoking, call Connecticut QuitLine at 1-800-QUIT-NOW.

Children and Adult services are available now with no wait time.  Please contact HBH Intake Department at 860-548-0101, option 2.

 


powered by centersite dot net